Partially mismatched blood cell transplants for high-risk hematologic malignancy

Bone Marrow Transplantation

Volumn 19, Issue 9, 1997, Pages 861-866

  Russell, J A ^a,b,c   Desai, S ^d   Herbut, B ^a   Brown, C ^a,b   Luider, J ^a   Ruether, J D ^a,b   Stewart, D ^a,b   Chaudhry, A ^a,b   Booth, K ^c   Jorgenson, K ^c   Coppes, M J ^c   Turner, A R ^d   Larratt, L ^d   Poon, M C ^a   Klassen, J ^a  

^a FOOTHILLS HOSPITAL   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d CROSS CANCER INSTITUTE   (Canada)

Author keywords

Allogeneic; Blood cell transplants; Mismatched; Peripheral blood progenitor cells

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD CELL; CELL TRANSPLANTATION; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DONOR; FAMILY; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL; T LYMPHOCYTE;

EID: 0030979637     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700757     Document Type: Article

References (27)

1. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA identical siblings. New Engl J Med 1985; 313: 765-771.
2. Anasettii C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197-204.
3. Spencer A, Szydlo RM, Brookes PA et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
4. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
5. Davies SM, Shu BR, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636-1642.
6. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
7. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
8. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
9. Körbling M, Huh YO, Durett A et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
10. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
11. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655-1658.
12. Azevedo WM, Aranha FJP, Gouvea JV et al. Allogeneic transplantation with blood stem cells mobilized by rh-G-CSF for hematological malignancies. Bone Marrow Transplant 1995; 16: 647-653.
13. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
14. Majolino I, Saglio G, Seime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 556-560.
15. Bacigalupo A, Van Lint MT, Valbonesi M et al. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with acute leukemia. Blood 1996; 88. 353-357.
16. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996; 18: 35-40.
17. Vaughan RW. PCR-SSO typing for HLA-DRB alleles. Eur J Immunogen 1991; 18: 69-80.
18. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1995; 84: 3948-3955.
19. Russell JA, Poon M-C, Jones AR et al. Allogeneic bone marrow transplantation for adults with malignancy without protective isolation. Lancet 1992; 339: 38-40.
20. Russell JA, Woodman RC, Poon M-C et al. Addition of low-dose folinic acid to a methotrexate/cyclosporin regimen for prevention of acute graft-versus-host disease. Bone Marrow Transplant 1994; 14: 397-401.
21. Gaiger A, Mannhalter C, Hinterberger W et al. Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematol 1991; 63: 227-228.
22. Barrett J. Graft-versus-host disease. In: Treleaven J, Barrett J (eds). Bone Marrow Transplantation in Practice. Churchill Livingstone: Edinburgh, 1992, pp 257-272.
23. Jansen J, Goselink HH, Veenhof WFJ et al. The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease. Exp Hematol 1983; 11: 967-973.
24. Atkinson K, Farrell C, Chapman G et al. Female donors increase the risk of acute graft-versus-host disease; effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986; 63: 231-239.
25. Martin PJ. Determinants of engraftment after allogeneic marrow transplantation. Blood 1993; 79: 1647-1650.
26. Bender JG, To LB, Williams, S, Schwarzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-341.
27. Antin JH. Graft-versus-leukemia: no longer an epiphenomenon. Blood 1993; 82: 2273-2277.